ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651850 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651850; 2) Community: the network communities that were significantly associated with the response to NSC 651850; 3) Molecule: the relationships between components within communities and NSC 651850; 4) MDR: the compounds that were significantly associated with the NSC 651850.

NSC Compound Enrichment Correlation
NSC 295501 Camptothecin Derivative 0.00457614317494024 0.60030509
NSC 333856 NSC 329083 0.00457614317494024 0.10975399
NSC 348894 Benzenesulfonamide, 4-[(9-acridinylmethyl)amino]-N-(aminoiminomethyl)- 0.00457614317494024 0.65906225
NSC 671002 Null 0.00457614317494024 0.63345131
NSC 684836 Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.00457614317494024 -0.0053355536
NSC 684838 Propanamide, 3,3,3-trifluoro-2-(trifluoromethyl)- N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.00457614317494024 -0.02078874
NSC 711993 Null 0.00457614317494024 0.25316118
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0045761431749403 0.46716866
NSC 660147 Trimethyl 2-phosphono-3-(2-furan)acrylate 0.00628187335688605 0.053237512
NSC 683555 Camptothecin Derivative 0.00628187335688605 0.47139751
Total:52  Current:7    [First] [Prev] [Next] [Last]